GI
STOK icon

GAMMA Investing’s Stoke Therapeutics STOK Stock Holding History

GAMMA Investing’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Buy
883
+43
+5% +$1.38K ﹤0.01% 2640
2026
Q1 		$27.4K Buy
840
+10
+1% +$328 ﹤0.01% 2550
2025
Q4 		$26.3K Buy
830
+150
+22% +$4.51K ﹤0.01% 2455
2025
Q3 		$16K Buy
680
+41
+6% +$703 ﹤0.01% 2640
2025
Q2 		$7.25K Sell
639
-167
-21% -$1.59K ﹤0.01% 2965
2025
Q1 		$5.36K Buy
806
+530
+192% +$4.94K ﹤0.01% 3060
2024
Q4 		$3.04K Sell
276
-247
-47% -$3.03K ﹤0.01% 3087
2024
Q3 		$6.43K Buy
523
+270
+107% +$3.83K ﹤0.01% 2644
2024
Q2 		$3.42K Buy
253
+136
+116% +$1.84K ﹤0.01% 2705
2024
Q1 		$1.58K Buy
+117
New +$709 ﹤0.01% 2823

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM

GAMMA Investing's STOK Position: Q2 2026 in Review

GAMMA Investing increased its Stoke Therapeutics (STOK) stake by 5.1% in Q2 2026, buying an estimated $1.38K and bringing the position to 883 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

GAMMA Investing first reported a position in STOK in Q1 2024 and has held it in 10 quarters since. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • GAMMA Investing held 883 shares of Stoke Therapeutics worth $28.9K as of Q2 2026.
  • GAMMA Investing bought 43 Stoke Therapeutics shares in Q2 2026, an estimated $1.38K.
  • Stoke Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2640 holding.
  • GAMMA Investing first reported a position in Stoke Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.